Prior hypothermia attenuates malignant hyperthermia in susceptible swine

Anesthesia and Analgesia

Volumn 82, Issue 4, 1996, Pages 803-809

  Iaizzo, Paul A ^a,c   Kehler, Chris H ^a   Carr, Richard J ^a   Sessler, Daniel I ^b   Belani, Kumar G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Box 294 UMHC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; HALOTHANE; INHALATION ANESTHETIC AGENT; KETAMINE; MUSCLE RELAXANT AGENT; PANCURONIUM; SUXAMETHONIUM; THIOPENTAL;

ANESTHESIA COMPLICATION; ANESTHETIC RECOVERY; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEMODYNAMIC MONITORING; HYPOTHERMIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT HYPERTHERMIA; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; HALOTHANE; HEMODYNAMIC PROCESSES; HYPOTHERMIA, INDUCED; MALIGNANT HYPERTHERMIA; SUCCINYLCHOLINE; SWINE;

EID: 0029930066     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199604000-00022     Document Type: Article

References (15)

1. Britt BA, Kalow W. Malignant hypertherrnia: a statistical review. Can Anaesth Soc J 1970;17:293-315.
2. Ellis FR, Halsall PJ. Malignant hyperpyrexia. Br J Hosp Med 1980;24:318-27.
3. Ørding H. Incidence of malignant hyperthermia in Denmark. Anesth Analg 1985;64:700-4.
4. Gronert GA. Malignant hyperthermia. In: Engel AG, Franzini-Armstrong C, eds. Myology. New York: McGraw-Hill, 1994: 1661-78.
5. Iaizzo PA, Palahniuk RJ. Malignant hyperthermia: diagnosis, treatment, genetics and pathophysiology. Invest Radiol 1991;26: 1013-8.
6. Wedel DJ. The effect of age on the development of malignant hyperthermia in susceptible piglets [abstract]. Anesthesiology 1994;81:A426.
7. Iaizzo PA, Wedel DJ. Episodes of malignant hyperthermia induced by the depolarizing muscle relaxant succinylcholine. Anesth Analg 1994;79:143-51.
8. Deleted in proof.
9. Nelson TE. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology 1990; 73:449-54.
10. Wedel DJ, Iaizzo PA, Milde JH. Desflurane is a trigger of malignant hyperthermia in susceptible swine. Anesthesiology 1991;74:508-12.
11. Wedel DJ, Gammel SA, Milde JH, Iaizzo PA. Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared to halothane in susceptible swine. Anesthesiology 1993;78:1138-44.
12. Gronert GA. Malignant hyperthermia. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill; 1986:1763-84.
13. Gillard EF, Otsu K, Fujii J, et al. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991;11:751-5.
14. Iaizzo PA, Kehler CH, Belani KG, et al. Thermal response in acute porcine malignant hyperthermia. Anesth Analg 1996; 82: 782-9.
15. Wedel DJ, Quinlan JG, Iaizzo PA. Clinical effects of intravenously administered dantrolene. Mayo Clin Proc 1995;70:241-6.